2.04
-0.01(-0.49%)
Currency In USD
| Previous Close | 2.05 |
| Open | 2.03 |
| Day High | 2.1 |
| Day Low | 2.03 |
| 52-Week High | 2.63 |
| 52-Week Low | 1.59 |
| Volume | 159,652 |
| Average Volume | 218,670 |
| Market Cap | 114.93M |
| PE | -1.47 |
| EPS | -1.39 |
| Moving Average 50 Days | 2.12 |
| Moving Average 200 Days | 2.15 |
| Change | -0.01 |
If you invested $1000 in Seer, Inc. (SEER) since IPO date, it would be worth $36.13 as of August 20, 2025 at a share price of $2.04. Whereas If you bought $1000 worth of Seer, Inc. (SEER) shares 3 years ago, it would be worth $204 as of August 20, 2025 at a share price of $2.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire Inc.
Jul 31, 2025 8:05 PM GMT
REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Canaccord Genuity 45th
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
GlobeNewswire Inc.
Jul 22, 2025 8:05 PM GMT
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2025 on Wednesday
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
GlobeNewswire Inc.
Jun 01, 2025 11:00 AM GMT
First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics Seer’s new Proteograph ONE Assay to accelerate analysis and reduce costs, making la